-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NvlZR8gj0tUfjMsJ8uOTEoZqZm538mS4YudUpat1O5aDLzNmwEmutVXDNnlrMuxl ab+beqQDMUOIg8ZuMNxCqA== 0000950133-99-003386.txt : 19991105 0000950133-99-003386.hdr.sgml : 19991105 ACCESSION NUMBER: 0000950133-99-003386 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19991104 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: INKINE PHARMACEUTICAL CO INC CENTRAL INDEX KEY: 0000929547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133754005 STATE OF INCORPORATION: NY FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-47845 FILM NUMBER: 99740851 BUSINESS ADDRESS: STREET 1: 1720 WALTON RD STREET 2: SUITE 200 CITY: BLUE BELL STATE: PA ZIP: 19422 BUSINESS PHONE: 6102609350 MAIL ADDRESS: STREET 1: 1720 WALTON RD STREET 2: SUITE 200 CITY: BLUE BELL STATE: PA ZIP: 19422 FORMER COMPANY: FORMER CONFORMED NAME: PANAX PHARMACEUTICAL CO LTD DATE OF NAME CHANGE: 19940906 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: TAIL WIND FUND LTD CENTRAL INDEX KEY: 0001074435 STANDARD INDUSTRIAL CLASSIFICATION: [] FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: WINDERMERE HOUSE STREET 2: 404 EAST BAY STREET P O BOX SS-5539 CITY: BRITISH VIRGIN ISLES SC 13G 1 SCHEDULE 13G 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. ______________)(1) InKine Pharmaceutical Company, Inc. (Name of Issuer) Common Stock, par value $.0001 per share (Title of Class of Securities) 457214 10 4 (CUSIP Number) September 20, 1999 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which Schedule is filed: / / Rule 13d-1(b) /X/ Rule 13d-1(c) / / Rule 13d-1(d) - -------- (1)The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities and Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 2 - ----------------------- ------------------- CUSIP No. 457214 10 4 13G Page 2 of 6 - ----------------------- ------------------- ================================================================================ 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY) The Tail Wind Fund, Ltd. ================================================================================ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] ================================================================================ 3 SEC USE ONLY ================================================================================ 4 CITIZENSHIP OR PLACE OF ORGANIZATION British Virgin Islands ================================================================================ 5 SOLE VOTING POWER 2,046,153 NUMBER OF SHARES ================================================== BENEFICIALLY 6 SHARED VOTING POWER 0 OWNED BY EACH ================================================== REPORTING 7 SOLE DISPOSITIVE POWER 2,046,153 ================================================== PERSON WITH 8 SHARED DISPOSITIVE POWER 0 ================================================================================ 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,046,153 ================================================================================ 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* 9 ================================================================================ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.6% ================================================================================ 12 TYPE OF REPORTING PERSON* OO ================================================================================ *SEE INSTRUCTIONS BEFORE FILLING OUT! 3 - ----------------------- ------------------- CUSIP No. 457214 10 4 13G Page 3 of 6 - ----------------------- ------------------- ITEM 1(a). NAME OF ISSUER: InKine Pharmaceutical Company, Inc. ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: Sentry Park East 1720 Walton Road Blue Bell, PA 19432 ITEM 2(a). NAME OF PERSON FILING: The Tail Wind Fund, Ltd. ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: Windermere House 404 East Bay Street P.O. Box SS-5539 Nassau, Bahamas ITEM 2(c). CITIZENSHIP: British Virgin Islands ITEM 2(d). TITLE OF CLASS OF SECURITIES: This statement relates to the shares of common stock, par value $0.0001 per share (the "Common Stock"), of InKine Pharmaceutical Company, Inc., a New York corporation (the "Company"). ITEM 2(e). CUSIP NUMBER: 457214 10 4 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b), OR 13d-2(b), CHECK WHETHER THE PERSON FILING IS A: (a) [ ] Broker or dealer registered under Section 15 of the Exchange Act. (b) [ ] Bank as defined in Section 3(a)(6) of the Exchange Act. 4 - ----------------------- ------------------- CUSIP No. 457214 10 4 13G Page 4 of 6 - ----------------------- ------------------- (c) [ ] Insurance company as defined in Section 3(a)(19) of the Exchange Act. (d) [ ]Investment company registered under Section 8 of the Investment Company Act. (e) [ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; (j) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J). If this statement is filed pursuant to Rule 13d-1(c), check this box.[X] ITEM 4. OWNERSHIP. (a) Amount beneficially owned: 2,046,153 shares, which includes 507,692 shares that may be acquired upon exercise of certain warrants. (b) Percent of class: 7.6% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: 2,046,153 5 - ----------------------- ------------------- CUSIP No. 457214 10 4 13G Page 5 of 6 - ----------------------- ------------------- (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or to direct the disposition of: 2,046,153 (iv) Shared power to dispose or to direct the disposition of: 0 ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. Not applicable. ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Not applicable. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY. Not applicable. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. Not applicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP. None. ITEM 10. CERTIFICATION. "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of and with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect." 6 - ----------------------- ------------------- CUSIP No. 457214 10 4 13G Page 6 of 6 - ----------------------- ------------------- SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. November 1, l999 ---------------- The Tail Wind Fund, Ltd. ------------------------ By: /s/ Michael Darville -------------------- Michael Darville, Vice President, Treasurer, Director By: /s/ Jason McCarroll ------------------- Jason McCarroll, Authorized Signatory -----END PRIVACY-ENHANCED MESSAGE-----